Nicotine might have a protective effect in the etiology of multiple sclerosis

Abstract

Objective:

The use of moist snuff is common in Sweden and leads to exposure to high doses of nicotine. Recent studies indicate that exposure to nicotine could modulate immune responses. The aim of this study was to investigate the influence of snuff use on the risk of developing multiple sclerosis (MS), taking smoking habits into consideration.

Methods:

In two Swedish population-based, case-control studies (7883 cases, 9437 controls), subjects with different snuff use habits were compared regarding MS risk, by calculating odds ratios (ORs) with 95% confidence intervals (CIs).

Results:

Snuff-takers have a decreased risk of developing MS compared with those who have never used moist snuff (OR 0.83, 95% CI 0.75–0.92), and we found clear evidence of an inverse dose-response correlation between cumulative dose of snuff use and the risk of developing the disease. We further observed that subjects who combined smoking and snuff use had a significantly lower risk for MS than smokers who had never used moist snuff, also after adjustment for amount of smoking.

Conclusions:

Our results add evidence to the hypothesis that nicotine exerts anti-inflammatory and immune-modulating effects in a way that might decrease the risk of developing MS.

Keywords

Multiple sclerosis immunology snuff use

Get full access to this article

View all access options for this article.

References

Filippini

Cesario

Fini

. The yin and yang of non-neuronal alpha7 nicotinic receptors in inflammation and autoimmunity. Curr Drug Targets 2012; 5: 644–655.

Hedström

Bäärnhielm

Olsson

. Tobacco smoking, but not Swedish snuff usage, increases the risk of multiple sclerosis. Neurology 2009; 73: 696–701.

Carlens

Hergens

Grunewald

. Smoking, use of moist snuff, and risk of chronic inflammatory diseases. Am J Respir Crit Care Med 2010; 181: 1217–1222.

SMSreg. Välkommen till Svenska MS-registret, www.msreg.net (accessed 30 October 2012).

Thompson

Montalban

Barkhof

. Diagnostic criteria for primary progressive multiple sclerosis: A position paper. Ann Neurol 2000; 47: 831–835.

Hedström

Åkerstedt

Hillert

. Shift work at young age is associated with increased risk for multiple sclerosis. Ann Neurol 2011; 67; 110–117.

Wingerchuk

Smoking: Effects on multiple sclerosis susceptibility and disease progression. Ther Adv Neurol Disord 2012; 5: 13–22.

Cnattingius

Galanti

Grafström

. Statens folkhälsoinstitut. Hälsorisker med svenskt snus. (available at http://www.fhi.se/PageFiles/3094/a200515snusrapport0512yy.pdf).

Sopori

Effects of cigarette smoke on the immune system. Nat Rev Immunol 2002; 2: 372–377.

10.

Piao

Campagnolo

Dayao

. Nicotine and inflammatory neurological disorders. 2009; 30: 715–722.

11.

Ulloa

The vagus nerve and the nicotinic anti-inflammatory pathway. Nat Rev Drug Discov 2005; 4: 673–684.

12.

Nizri

Irony-Tur-Sinai

Lory

. Activation of the cholinergic anti-inflammatory system by nicotine attenuates neuroinflammation via suppression of Th1 and Th17 responses. J Immunol 2009; 183: 6681–6688.

13.

De Jonge

Ulloa

The alpha7 nicotinic acetylcholine receptor as a pharmacological target for inflammation. Br J Pharmacol 2007; 151: 915–929.